Neptune Technologies and Bioressources Inc.   Report issue

For profit Phase 4
Founded: Laval Canada (1925)
Status: No NME R&D (1925)

Organization Overview

First Clinical Trial
2009
NCT00867828
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Neptune | NeuroBioPharm Inc.

Active Ingredients

Drugs in Phase 4 Trials (1)

krill oil (1 trial)

Drugs in Other Trials (2)

icosapent ethyl (vascepa) (1 trial)

water (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3